IL-17 and IL-21: Their Immunobiology and Therapeutic Potentials

키워드

참고문헌 (159)

1. Hiam-Galvez KJ, "Systemic immunity in cancer", Nat Rev Cancer, 21, pp.345~359 (2021)
2. O’Shea JJ, "Cytokines and autoimmunity", Nat Rev Immunol, 2, pp.37~45 (2002)
3. Mills KH, "IL-17 and IL-17-producing cells in protection versus pathology", Nat Rev Immunol, 23, pp.38~54 (2023)
4. Akuzum B, "Context-dependent regulation of type17 immunity by microbiota at the intestinal barrier", Immune Netw, 22, pp.e46~ (2022)
5. Akamatsu N, "Selected IL-21r expression and apoptosis induction by IL-21 in follicular lymphoma", Blood, 104, pp.2284~ (2004)
6. Ozaki K, "A critical role for IL-21 in regulating immunoglobulin production", Science, 298, pp.1630~1634 (2002)
7. Brandt K, "Interleukin-21 inhibits dendritic cell activation and maturation", Blood, 102, pp.4090~4098 (2003)
8. Dong C, "Cytokine regulation and function in T cells", Annu Rev Immunol, 39, pp.51~76 (2021)
9. McGeachy MJ, "The IL-17 family of cytokines in health and disease", Immunity, 50, pp.892~906 (2019)
10. Kim BS, "Generation of RORγt+ antigen-specific T regulatory 17 cells from Foxp3 precursors in autoimmunity", Cell Reports, 21, pp.195~207 (2017)
11. Kim BS, "Type 17 immunity promotes the exhaustion of CD8+ T cells in cancer", J Immunother Cancer, 9, pp.e002603~ (2021)
12. Veldhoen M, "Interleukin 17 is a chief orchestrator of immunity", Nat Immunol, 18, pp.612~621 (2017)
13. Shimura E, "Potential role of myeloid cell", eosinophil-derived IL-17 in LPS-induced endotoxin shock, 2014, pp.453, 1~6
14. Li L, "IL-17 produced by neutrophils regulates IFN-γ-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury", J Clin Invest, 120, pp.331~342 (2010)
15. Werner JL, "Neutrophils produce interleukin 17A(IL-17A)in a dectin-1-and IL-23-dependent manner during invasive fungal infection", Infect Immun, 79, pp.3966~3977 (2011)
16. Su Y, "Interleukin-17 receptor D constitutes an alternative receptor for interleukin-17A important in psoriasis-like skin inflammation", Sci Immunol, 4, pp.eaau9657~ (2019)
17. Huang J, "Interleukin-17D regulates group 3 innate lymphoid cell function through its receptor CD93", Immunity, 54, pp.673~686 (2021)
18. Ivanov II, "Transcriptional regulation of Th17 cell differentiation", Semin Immunol, 19, pp.409~417 (2007)
19. Ye P, "Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense", J Exp Med, 194, pp.519~527 (2001)
20. Chang SH, "Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor", J Biol Chem, 281, pp.35603~35607 (2006)
21. Qian Y, "The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease", Nat Immunol, 8, pp.247~256 (2007)
22. Schwandner R, "Requirement of tumor necrosis factor receptor-associated factor(TRAF)6 in interleukin 17 signal transduction", J Exp Med, 191, pp.1233~1240 (2000)
23. Qu F, "TRAF6-dependent Act1 phosphorylation by the IκB kinase-related kinases suppresses interleukin-17-induced NF-κB activation", Mol Cell Biol, 32, pp.3925~3937 (2012)
24. Liu C, "Act1, a U-box E3 ubiquitin ligase for IL-17 signaling", Sci Signal, 2, pp.ra63~ (2009)
25. Li X, "IL-17 receptor-based signaling and implications for disease", Nat Immunol, 20, pp.1594~1602 (2019)
26. Chong WP, "The cytokine IL-17a limits th17 pathogenicity via a negative feedback loop driven by autocrine induction of IL-24", Immunity, 53, pp.384~397 (2020)
27. Zhong B, "Negative regulation of IL-17-mediated signaling and inflammation by the ubiquitin-specific protease USP25", Nat Immunol, 13, pp.1110~1117 (2012)
28. Lee JS, "Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability", Immunity, 43, pp.727~738 (2015)
29. Conti HR, "Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis", J Exp Med, 206, pp.299~311 (2009)
30. Liang SC, "Interleukin(IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides", J Exp Med, 203, pp.2271~2279 (2006)
31. Conti HR, "IL-17 receptor signaling in oral epithelial cells is critical for protection against oropharyngeal candidiasis", Cell Host Microbe, 20, pp.606~617 (2016)
32. Cho JS, "IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice", J Clin Invest, 120, pp.1762~1773 (2010)
33. Chen X, "IL-17R-EGFR axis links wound healing to tumorigenesis in Lrig1+ stem cells", J Exp Med, 216, pp.195~214 (2019)
34. Lai Y, "The antimicrobial protein REG3A regulates keratinocyte proliferation and differentiation after skin injury", Immunity, 37, pp.74~84 (2012)
35. Krstić J, "Urokinase type plasminogen activator mediates interleukin-17-induced peripheral blood mesenchymal stem cell motility and transendothelial migration", Biochim Biophys Acta, 1853, pp.431~444 (2015)
36. Ozaki K, "Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain", Proc Natl Acad Sci U S A, 97, pp.11439~11444 (2000)
37. Wei L, "IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner", J Biol Chem, 282, pp.34605~34610 (2007)
38. Suto A, "Development and characterization of IL-21-producing CD4+ T cells", J Exp Med, 205, pp.1369~1379 (2008)
39. Lee GR, "Molecular mechanisms of t helper cell differentiation and functional specialization", Immune Netw, 23, pp.e4~ (2023)
40. Coquet JM, "IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production", J Immunol, 178, pp.2827~2834 (2007)
41. Bae EA, "Roles of NKT cells in cancer immunotherapy", Arch Pharm Res, 42, pp.543~548 (2019)
42. Spolski R, "IL-21 and T follicular helper cells", Int Immunol, 22, pp.7~12 (2010)
43. Nurieva RI, "Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages", Immunity, 29, pp.138~149 (2008)
44. Vogelzang A, "A fundamental role for interleukin-21 in the generation of T follicular helper cells", Immunity, 29, pp.127~137 (2008)
45. Bryant VL, "Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells : predominant role of IL-21 produced by CXCR5+ T follicular helper cells", J Immunol, 179, pp.8180~8190 (2007)
46. Ming S, "GITR promotes the polarization of TFH-like cells in helicobacter pylori-positive gastritis", Front Immunol, 12, pp.736269~ (2021)
47. Koh CH, "GITR agonism triggers antitumor immune responses through IL21-expressing follicular helper T cells", Cancer Immunol Res, 8, pp.698~709 (2020)
48. Oja AE, "GITR shapes humoral immunity by controlling the balance between follicular T helper cells and regulatory T follicular cells", Immunol Lett, 222, pp.73~79 (2020)
49. Jin H, "Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis", J Immunol, 173, pp.657~665 (2004)
50. Spolski R, "Interleukin-21 : basic biology and implications for cancer and autoimmunity", Annu Rev Immunol, 26, pp.57~79 (2008)
51. Wan CK, "Opposing roles of STAT1 and STAT3 in IL-21 function in CD4+ T cells", Proc Natl Acad Sci U S A, 112, pp.9394~9399 (2015)
52. Solaymani-Mohammadi S, "Regulation of intestinal epithelial cell cytoskeletal remodeling by cellular immunity following gut infection", Mucosal Immunol, 6, pp.369~378 (2013)
53. Strengell M, "IL-21 up-regulates the expression of genes associated with innate immunity and Th1 response", J Immunol, 169, pp.3600~3605 (2002)
54. Spolski R, "Interleukin-21 : a double-edged sword with therapeutic potential", Nat Rev Drug Discov, 13, pp.379~395 (2014)
55. Kwon H, "Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors", Immunity, 31, pp.941~952 (2009)
56. Li P, "BATF-JUN is critical for IRF4-mediated transcription in T cells", Nature, 490, pp.543~546 (2012)
57. Ciofani M, "A validated regulatory network for Th17 cell specification", Cell, 151, pp.289~303 (2012)
58. Glasmacher E, "A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes", Science, 338, pp.975~980 (2012)
59. Seo H, "BATF and IRF4 cooperate to counter exhaustion in tumor-infiltrating CAR T cells", Nat Immunol, 22, pp.983~995 (2021)
60. Distler JH, "Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis", Arthritis Rheum, 52, pp.856~864 (2005)
61. Caruso R, "IL-21 is highly produced in Helicobacter pylori-infected gastric mucosa and promotes gelatinases synthesis", J Immunol, 178, pp.5957~5965 (2007)
62. Crotty S, "Follicular helper CD4 T cells(TFH)", Annu Rev Immunol, 29, pp.621~663 (2011)
63. Yang L, "IL-21 and TGF-beta are required for differentiation of human T(H)17 cells", Nature, 454, pp.350~352 (2008)
64. Zhou L, "IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways", Nat Immunol, 8, pp.967~974 (2007)
65. Nurieva R, "Essential autocrine regulation by IL-21 in the generation of inflammatory T cells", Nature, 448, pp.480~483 (2007)
66. Brüstle A, "The development of inflammatory TH-17 cells requires interferon-regulatory factor 4", Nat Immunol, 8, pp.958~966 (2007)
67. Chen Q, "IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor", Immunity, 29, pp.899~911 (2008)
68. Nurieva RI, "Bcl6 mediates the development of T follicular helper cells", Science, 325, pp.1001~1005 (2009)
69. Yu D, "The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment", Immunity, 31, pp.457~468 (2009)
70. Yu J, "Interleukin-21 promotes the development of ulcerative colitis and regulates the proliferation and secretion of follicular T helper cells in the colitides microenvironment", Mol Med Rep, 11, pp.1049~1056 (2015)
71. Gassen RB, "IL-21 treatment recovers follicular helper T cells and neutralizing antibody production in respiratory syncytial virus infection", Immunol Cell Biol, 99, pp.309~322 (2021)
72. Strengell M, "IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells", J Immunol, 170, pp.5464~5469 (2003)
73. Monteleone G, "Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn’s disease", Gastroenterology, 128, pp.687~694 (2005)
74. Zeng R, "Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function", J Exp Med, 201, pp.139~148 (2005)
75. Casey KA, "IL-21 promotes differentiation of naive CD8 T cells to a unique effector phenotype", J Immunol, 178, pp.7640~7648 (2007)
76. Hinrichs CS, "IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy", Blood, 111, pp.5326~5333 (2008)
77. Zander R, "Tfh-cell-derived interleukin 21 sustains effector CD8+ T cell responses during chronic viral infection", Immunity, 55, pp.475~493 (2022)
78. Rankin AL, "IL-21 receptor is critical for the development of memory B cell responses", J Immunol, 186, pp.667~674 (2011)
79. Rankin AL, "IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL", MpJ-Fas(lpr, J mice, pp.J Immunol, 2012[DOI]
80. Pène J, "Cutting edge : IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells", J Immunol, 172, pp.5154~5157 (2004)
81. Avery DT, "IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4", J Immunol, 181, pp.1767~1779 (2008)
82. Ettinger R, "The role of IL-21 in regulating B-cell function in health and disease", Immunol Rev, 223, pp.60~86 (2008)
83. Ozaki K, "Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6", J Immunol, 173, pp.5361~5371 (2004)
84. Konforte D, "IL-21 : an executor of B cell fate", J Immunol, 182, pp.1781~1787 (2009)
85. Linterman MA, "IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses", J Exp Med, 207, pp.353~363 (2010)
86. Gonzalez DG, "Nonredundant roles of IL-21 AND IL-4 in the phased initiation of germinal center B cells and subsequent self-renewal transitions", J Immunol, 201, pp.3569~3579 (2018)
87. Avery DT, "STAT3 is required for IL-21-induced secretion of IgE from human naive B cells", Blood, 112, pp.1784~1793 (2008)
88. Berglund LJ, "IL-21 signalling via STAT3 primes human naive B cells to respond to IL-2 to enhance their differentiation into plasmablasts", Blood, 122, pp.3940~3950 (2013)
89. Korn T, "IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells", Nature, 448, pp.484~487 (2007)
90. Attridge K, "IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis", Blood, 119, pp.4656~4664 (2012)
91. Huber M, "IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype", Proc Natl Acad Sci U S A, 105, pp.20846~20851 (2008)
92. Piao WH, "IL-21 modulates CD4+ CD25+ regulatory T-cell homeostasis in experimental autoimmune encephalomyelitis", Scand J Immunol, 67, pp.37~46 (2008)
93. Pot C, "Cutting edge : IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells", J Immunol, 183, pp.797~801 (2009)
94. Spolski R, "IL-21 mediates suppressive effects via its induction of IL-10", J Immunol, 182, pp.2859~2867 (2009)
95. Kasaian MT, "IL-21 limits NK cell responses and promotes antigen-specific T cell activation : a mediator of the transition from innate to adaptive immunity", Immunity, 16, pp.559~569 (2002)
96. Skak K, "Interleukin-21 activates human natural killer cells and modulates their surface receptor expression", Immunology, 123, pp.575~583 (2008)
97. Seo H, "IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours", Nat Commun, 8, pp.15776~ (2017)
98. Yano M, "IL-21-expanded natural killer cells as autologous cell therapy for cll", Blood, 134, pp.4302~ (2019)
99. Strengell M, "IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells", J Leukoc Biol, 79, pp.1279~1285 (2006)
100. Wan CK, "The cytokines IL-21 and GM-CSF have opposing regulatory roles in the apoptosis of conventional dendritic cells", Immunity, 38, pp.514~527 (2013)
101. De Nitto D, "Interleukin-21 triggers effector cell responses in the gut", World J Gastroenterol, 16, pp.3638~3641 (2010)
102. van Heel DA, "A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21", Nat Genet, 39, pp.827~829 (2007)
103. Asano K, "Molecular scanning of interleukin-21 gene and genetic susceptibility to type 1 diabetes", Hum Immunol, 68, pp.384~391 (2007)
104. Teixeira VH, "Testing for the association of the KIAA1109", Tenr, IL21 gene region with rheumatoid arthritis in a European family-based study, pp.Arthritis Res Ther, 2009[DOI]
105. Costanzo A, "IL-21 in the pathogenesis and treatment of skin diseases", J Dermatol Sci, 60, pp.61~66 (2010)
106. Park Y, "Recent advances in cell therapeutics for systemic autoimmune diseases", Immune Netw, 22, pp.e10~ (2022)
107. Matusevicius D, "Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis", Mult Scler, 5, pp.101~104 (1999)
108. Komiyama Y, "IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis", J Immunol, 177, pp.566~573 (2006)
109. Tzartos JS, "Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis", Am J Pathol, 172, pp.146~155 (2008)
110. Kotake S, "IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis", J Clin Invest, 103, pp.1345~1352 (1999)
111. Ziolkowska M, "High levels of IL-17 in rheumatoid arthritis patients : IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism", J Immunol, 164, pp.2832~2838 (2000)
112. Sato K, "Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction", J Exp Med, 203, pp.2673~2682 (2006)
113. Nakae S, "Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice", J Immunol, 171, pp.6173~6177 (2003)
114. Wong CK, "Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus : implications for Th17-mediated inflammation in auto-immunity", Clin Immunol, 127, pp.385~393 (2008)
115. Johansen C, "Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin", Br J Dermatol, 160, pp.319~324 (2009)
116. Schüler R, "Antagonization of IL-17a attenuates skin inflammation and vascular dysfunction in mouse models of psoriasis", J Invest Dermatol, 139, pp.638~647 (2019)
117. Stolfi C, "Involvement of interleukin-21 in the regulation of colitis-associated colon cancer", J Exp Med, 208, pp.2279~2290 (2011)
118. Gensous N, "T follicular helper cells in autoimmune disorders", Front Immunol, 9, pp.1637~ (2018)
119. Wang S, "IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE", Nat Commun, 9, pp.1758~ (2018)
120. Wang Y, "IL-21", IL-21R signaling suppresses intestinal inflammation induced by DSS through regulation of Th responses in lamina propria in mice, 2016, pp.6, 31881~
121. Fina D, "Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease", Gut, 57, pp.887~892 (2008)
122. Caruso R, "Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis", Nat Med, 15, pp.1013~1015 (2009)
123. Wang Y, "Interleukin-21 is associated with the severity of psoriasis vulgaris through promoting CD4+ T cells to differentiate into Th17 cells", Am J Transl Res, 8, pp.3188~3196 (2016)
124. Shi Y, "IL-21 induces an imbalance of Th17", Treg cells in moderate-to-severe plaque psoriasis patients, 2019, pp.10, 1865~
125. Dolff S, "Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus", Arthritis Res Ther, 13, pp.R157~ (2011)
126. Coffelt SB, "IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis", Nature, 522, pp.345~348 (2015)
127. Wu P, "γδT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer", Immunity, 40, pp.785~800 (2014)
128. Ma S, "IL-17A produced by γδ T cells promotes tumor growth in hepatocellular carcinoma", Cancer Res, 74, pp.1969~1982 (2014)
129. Zhuang Y, "CD8+ T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer", Gastroenterology, 143, pp.951~962 (2012)
130. Chung L, "Bacteroides fragilis toxin coordinates a pro-carcinogenic inflammatory cascade via targeting of colonic epithelial cells(vol 23, pg 203, 2018)", Cell Host Microbe, 23, pp.421~421 (2018)
131. Chang SH, "T helper 17 cells play a critical pathogenic role in lung cancer", Proc Natl Acad Sci U S A, 111, pp.5664~5669 (2014)
132. Jin C, "Commensal microbiota promote lung cancer development via gamma delta T cells", Cell, 176, pp.998~1013 (2019)
133. Takeuchi A, "IL-17 production by γδ T cells is important for the antitumor effect of Mycobacterium bovis bacillus Calmette-Guérin treatment against bladder cancer", Eur J Immunol, 41, pp.246~251 (2011)
134. Chen CL, "IL-17 induces antitumor immunity by promoting beneficial neutrophil recruitment and activation in esophageal squamous cell carcinoma", OncoImmunology, 7, pp.e1373234~ (2018)
135. Deng S, "Targeting tumors with IL-21 reshapes the tumor microenvironment by proliferating PD-1intTim-3-CD8+ T cells", JCI Insight, 5, pp.e132000~ (2020)
136. Topchyan P, "Harnessing the IL-21-batf pathway in the CD8+ T cell anti-tumor response", Cancers(Basel), 13, pp.1263~ (2021)
137. Wang G, "In vivo antitumor activity of interleukin 21 mediated by natural killer cells", Cancer Res, 63, pp.9016~9022 (2003)
138. Takaki R, "IL-21 enhances tumor rejection through a NKG2D-dependent mechanism", J Immunol, 175, pp.2167~2173 (2005)
139. Gowda A, "IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cells in vitro", Blood, 111, pp.4723~4730 (2008)
140. de Totero D, "The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK", STAT and ERK1, Blood, pp.2008, 111[DOI]
141. Akamatsu N, "High IL-21 receptor expression and apoptosis induction by IL-21 in follicular lymphoma", Cancer Lett, 256, pp.196~206 (2007)
142. Sarosiek KA, "Interleukin-21-induced apoptosis and cell death of diffuse large B-cell lymphoma(DLBCL)cell lines and primary tumors are associated with an induction of bim", Blood, 108, pp.2503~ (2006)
143. Sarosiek KA, "Interleukin-21 induces cell cycle arrest and apoptosis of diffuse large b-cell lymphomas(DLBCL)via activation of stat3 and upregulation of c-myc", Blood, 112, pp.225~225 (2008)
144. Jung SM, "Targeted immunotherapy for autoimmune disease", Immune Netw, 22, pp.e9~ (2022)
145. Yin Y, "Efficacy and safety of IL-17 inhibitors for the treatment of ankylosing spondylitis : a systematic review and meta-analysis", Arthritis Res Ther, 22, pp.111~ (2020)
146. Drakos A, "A review of the clinical trial landscape in psoriasis : an update for clinicians", Dermatol Ther(Heidelb), 12, pp.2715~2730 (2022)
147. Almassian B, "Carg-2020, an oncolytic artificial virus co-delivering three immunomodulators, to regress and cure established tumors in mice", J Clin Oncol, 39, pp.e14560~ (2021)
148. Denis A, "The 2023 pipeline of disease-modifying antirheumatic drugs(DMARDs)in clinical development for spondyloarthritis(including psoriatic arthritis) : a systematic review of trials", RMD Open, 9, pp.e003279~ (2023)
149. Nasonov E, "Developments of Russian original biological agents for the treatment of immunoinflammatory rheumatic diseases", Rheumatol Sci Pract, 55, pp.201~210 (2017)
150. Nie S, "Biology drives the discovery of bispecific antibodies as innovative therapeutics", Antib Ther, 3, pp.18~62 (2020)
151. Mullard A, "Bispecific antibody pipeline moves beyond oncology", Nat Rev Drug Discov, 16, pp.666~668 (2017)
152. Hua F, "Anti-IL21 receptor monoclonal antibody(ATR-107) : safety, pharmacokinetics, and pharmacodynamic evaluation in healthy volunteers : a phase I, first-in-human study", J Clin Pharmacol, 54, pp.14~22 (2014)
153. Danese S, "The future of drug development for inflammatory bowel disease : the need to ACT(advanced combination treatment)", Gut, 71, pp.2380~2387 (2022)
154. Zhang R, "Novel oncolytic virus armed with interleukin-21 enhances immune oncotherapy", Cancer Res, 79, pp.1462~1462 (2019)
155. Zhu Z, "Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways", Mol Cancer, 21, pp.196~ (2022)
156. Leonard WJ, "Strategies to therapeutically modulate cytokine action", Nat Rev Drug Discov, 22, pp.827~854 (2023)
157. Sullivan JM, "Generation of IL-21 INDUKINETM molecules for the treatment of cancer", Cancer Res, 83, pp.1829~1829 (2023)
158. Milovanovic J, "Interleukin-17 in chronic inflammatory neurological diseases", Front Immunol, 11, pp.947~ (2020)
159. Leonard WJ, "IL-21 signaling in immunity", F1000 Res, 5, pp.F1000~ (2016)

관련 논문AI추천